Medi Caps share news and announcements

NSE: MEDICAPQBSE: 523144Pharmaceuticals & BiotechnologySmall Cap

₹24.95₹0.05 (0.20%)BSE ₹25.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹25.00.

52-week range of BSE trades to 23 Oct 2026

₹21.00Low, 11 Mar 2026₹44.70High, 29 Oct 2025

Delivery only: shares bought must be paid for in full, with no selling on the same day.

Market cap: ₹31 Cr3,735th largest listed
P/E: Lossover the last 12 months
P/B: 0.3
Dividend yield: Nonein the last 12 months
ROE: −1.5%
ROCE: −8.7%
Debt to equity: 0.00
Volume, NSE: 1,595

Medi Caps share news and announcements

524 announcements, routine notices left out, newest first. Page 3 of 11.

Sep 2023
Aug 2023
- 17 Aug · Legal
  Till date read with SEBI Circular dated July 13, 2023, We hereby submitting detail of pending litigation/ assessment which .... (opens in a new tab)
- 11 Aug · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
  Adoption of New sets of Article of Association subject to approval of Members by special resolution in ensuing AGM. (opens in a new tab)
- 11 Aug · Management
  Appointment of Mr. Gajendra Singh (DIN: 10253991) as an Additional director under the category of Non- executive Independent Director of the company subject to approval of Members in ensuing AGM. (opens in a new tab)
- 11 Aug · Results
  In compliance with regulation 33 of SEBI (LODR) 2015 board of directors in their meeting held on 11th August 2023 have considered and approved the following businesses: A. un-audited standalone .... (opens in a new tab)
- 11 Aug · Results
  Board meeting outcome for Board Meeting held on 11th August, 2023 pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 (opens in a new tab)
- 4 Aug · Board meeting
  Meeting on 11 Aug 2023: quarterly results
- 4 Aug · Board meeting
  MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve Medi-caps Limited has informed .... (opens in a new tab)
Jul 2023
- 13 Jul · Management
  Intimation of Resignation of Sourabh Kumar Shrivas (DIN:09692160) Independent Director of the Company (opens in a new tab)
- 13 Jul · Management
  Intimation for Resignation of Akshit Garg (DIN:08576807) from the post of Non Executive Director of the Company (opens in a new tab)
May 2023
- 30 May · Dispatch Of Letters To The Holders Of Physical Shares In Terms Of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod-1/P/CIR/2023/37 Dated March 16, 2023 Regarding Mandatory Furnishing Of PAN, KYC Details And Nomination.
  Read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated March 16, 2023 (the 'SEBI Circular') we would like to .... (opens in a new tab)
- 23 May · Results
  Pursuant to provisions of the Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby enclosing the Standalone and Consolidated Audited .... (opens in a new tab)
- 23 May · Results
  We would like to inform you that the Board of Directors of the Company in their meeting held on today i.e. 23rd day of May, 2023, has inter alia transacted the following matters:- a) .... (opens in a new tab)
- 15 May · Board meeting
  Meeting on 23 May 2023: quarterly results
- 15 May · Board meeting
  MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 ,inter alia, to consider and approve In terms of Regulation 29 of SEBI .... (opens in a new tab)
Apr 2023
- 21 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2023.
  Please find enclosed herewith the Compliance Certificate as per Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 obtained from M/s. L.N. Joshi .... (opens in a new tab)
- 11 Apr · Compliance Certificate For The Year Ended On 31St March, 2023 As Per Regulation 7(2) And 7(3) Of SEBI (LODR) Regulations, 2015.
  Compliance Certificate duly signed by the .... (opens in a new tab)
Feb 2023
- 27 Feb · Legal
  We wish to state that the Company .... (opens in a new tab)
- 9 Feb · Board meeting
  We would like to inform you that, Board of Directors of the Company in their meeting held on today i.e. 09th February, 2023 has inter alia, considered and approved the following business .... (opens in a new tab)
- 9 Feb · Results
  In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Un-audited Standalone and Consolidated Financial .... (opens in a new tab)
- 1 Feb · Board meeting
  Meeting on 9 Feb 2023: quarterly results
- 1 Feb · Board meeting
  MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve INTIMATION FOR MEETING OF BOARD .... (opens in a new tab)
Dec 2022
- 20 Dec · Legal
  With reference to the Subject captioned above, we are in receipt of an email from your good office on 19th December, 2022 for discrepancy observed in the Standalone & Consolidated Cash .... (opens in a new tab)
Nov 2022
- 10 Nov · Results
  This is in Continuation of our letter no. MCL/BM/SE/2022-2023 dated 03rd November, 2022 regarding information of Board Meeting for consideration and approval of Standalone as well as Consolidated .... (opens in a new tab)
- 10 Nov · Board meeting
  We are pleased to inform that, Board of Directors at their meeting held on today i.e. 10th November, 2022 has considered and approved the following business along with the other routine .... (opens in a new tab)
- 3 Nov · Board meeting
  Meeting on 10 Nov 2022: quarterly results
- 3 Nov · Board meeting
  MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve With reference to the above mentioned .... (opens in a new tab)
Sep 2022
Aug 2022
Jul 2022
- 26 Jul · Board meeting
  Meeting on 4 Aug 2022: quarterly results
- 26 Jul · Board meeting
  MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 ,inter alia, to consider and approve the following businesses along .... (opens in a new tab)
Jun 2022
- 7 Jun · Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), For The Half Year Ended 31St March, 2022.
  From time to time and SEBI Circular No. SEBIIHO/CFD/CMD IICIRlP12021/662 dated November 22, 2021, we are pleased to submit .... (opens in a new tab)
May 2022
- 25 May · Results
  This is in Continuation of our letter no. MCL/BM/SE/2022-2023 dated 17th May, 2022 regarding information of Board Meeting for consideration and approval of Audited standalone and consolidated .... (opens in a new tab)
- 25 May · Board meeting
  With reference to the above captioned subject, we would like to inform you that the Board of Directors of the Company in their meeting held on today i.e. 25th day of May, 2022, transacted .... (opens in a new tab)
- 17 May · Board meeting
  Meeting on 25 May 2022: audited results and quarterly results
- 17 May · Board meeting
  MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve 1. the Standalone as well as Consolidated .... (opens in a new tab)
Apr 2022
- 20 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2022.
  Please find enclosed herewith the Compliance Certificate as per Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 obtained from Practicing Company .... (opens in a new tab)
- 11 Apr · Compliance Certificate For The Year Ended On 31St March, 2022 As Per Regulation 7(2) And 7(3) Of SEBI (LODR) Regulations, 2015.
  Compliance Certificate duly signed by the .... (opens in a new tab)
- 8 Apr · Disclosure
  Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 08, 2022 for Mrs. Kusum Mittal (opens in a new tab)
- 8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0